MeSH D013036 - infantile spasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D000073376:Epileptic syndromes
D013036:Â
Infantile spasms
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Vigabatrin | Vigabatrin |  | 2019-01-14 |  |  | |
| Glenmark Pharmaceuticals | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| NATCO Pharma | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Johnson & Johnson | Topiramate | Topamax |  | 1996-12-24 |  |  |
| Cipla | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Vigabatrin | Vigabatrin |  | 2019-12-03 |  |  | |
| Sanofi | Corticotropin | Acthar |  | 1982-01-01 |  |  |
| Aurobindo Pharma | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Vigabatrin | Vigabatrin |  | 2021-09-29 |  |  | |
| Barr Pharmaceuticals | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Dr Reddys Laboratories | Vigabatrin | Vigabatrin |  | 2018-11-20 |  |  |
| Topiramate | Topiramate |  | 2023-11-17 |  |  | |
| Zydus Therapeutics | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Vigabatrin | Vigabatrin |  | 2023-03-02 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
46%6/13
Phase 3
36%4/11
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use